Engineering geniposide-loaded solid lipid nanoparticles for sustained release and induced apoptosis in human lung cancer cells
RSC Pharmaceutics · 2026 · 3 (5) · 1229-1239
DOI: 10.1039/d6pm00179c ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Saumyadeep Bora und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Geniposide-loaded solid lipid nanoparticles (GSLN) improved intracellular drug delivery and sustained drug release, resulting in enhanced anticancer efficacy in A549 NSCLC cells as compared to pure geniposide.
Zitieren
APA
Bora, S., Jodha, B., Vidap, R., Patel, S., Pooja, D., & Kulhari, H. (2026). Engineering geniposide-loaded solid lipid nanoparticles for sustained release and induced apoptosis in human lung cancer cells. RSC Pharmaceutics, 3(5), 1229-1239. https://doi.org/10.1039/d6pm00179c
Vancouver
Bora S, Jodha B, Vidap R, Patel S, Pooja D, Kulhari H. Engineering geniposide-loaded solid lipid nanoparticles for sustained release and induced apoptosis in human lung cancer cells. RSC Pharmaceutics. 2026;3(5):1229-1239. doi:10.1039/d6pm00179c
BibTeX
@article{Bora2026,
author = {Bora, Saumyadeep and Jodha, Bhavana and Vidap, Raju and Patel, Sunita and Pooja, Deep and Kulhari, Hitesh},
title = {Engineering geniposide-loaded solid lipid nanoparticles for sustained release and induced apoptosis in human lung cancer cells},
journal = {RSC Pharmaceutics},
year = {2026},
volume = {3},
number = {5},
pages = {1229--1239},
doi = {10.1039/d6pm00179c}
}
EUVIMED